Accomplished global strategy leader with 20+ years of expertise in health outcomes and over 100 publications across diverse therapeutic areas. Secures access and reimbursement by integrating patient perspective into drug development. Established value, access, and reimbursement strategies in US, EU, Canada, Latin America, and Asia markets. Shapes products’ strategies by engaging payors, thought leaders, organizations, and experts to comprehensively understand the landscape and trends to ensure patient-centric solutions that resonate with stakeholders and prioritize patient needs. Leadership in pipeline, peri-launch, launch, and in-line marketed products.